Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 5Gynecologic 1

Conditions

Ovarian Neoplasms 4Uterine Cervical Neoplasms 2Uterine Cervical Dysplasia 1Squamous Intraepithelial Lesions 1Recurrence 1Precancerous Conditions 1Papillomavirus Infections 1Lung Neoplasms 1Folic Acid Deficiency 1Fallopian Tube Neoplasms 1Breast Neoplasms 1Atypical Squamous Cells of the Cervix 1

Interventions

pembrolizumab 33Paclitaxel 27Cyclophosphamide 25Carboplatin 23olaparib 21Fulvestrant 15fludarabine 14Trastuzumab 14aldesleukin 13Docetaxel 13Early Intervention, Educational 12Surveys and Questionnaires 11veliparib 10palbociclib 10Methods 10Gemcitabine 10Blood Specimen Collection 10Nivolumab 9Flow Cytometry 9Biopsy 9Bevacizumab 9sargramostim 8niraparib 7liposomal doxorubicin 7Therapeutics 7Taxes 7Standard of Care 7Psychiatric Rehabilitation 7Magnetic Resonance Spectroscopy 7talazoparib 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Breast Neoplasms × Folic Acid × Gynecologic × Clear all
NCT04024254 2026-03-04

A Study of Serum Folate Levels in Patients Treated With Olaparib

Rush University Medical Center

Phase 4 Completed
10 enrolled 14 charts
BreastGynecologic

Breast Neoplasms, Folic Acid Deficiency, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡